Pascal is a Senior Advisor at Jeito Capital, bringing over 40 years of international experience in the biopharmaceutical industry. He has held a range of operational and strategic leadership positions and has served on the boards of several private and public companies.

Throughout his career Pascal has remained dedicated to transforming the lives of patients with serious medical conditions through pioneering science, collaborative leadership, and a steadfast commitment to excellence. He is the former Global Head of Strategy and Business Development, as well as the Global Head of the Cell & Gene division at Novartis Oncology, where he led the development and global launch of the first approved cell and gene therapy in the U.S.  Following a 5-year tenure as CEO at Atara Biotherapeutics (ATRA), Pascal now serves as its Chairman, and as Independent Director at Ipsen (IPN) and Medincell (MEDCL).

He holds a Doctorate in Veterinary Medicine from Paul Sabatier University and an MBA from INSEAD.